Table I.
Pathological characteristics of patients with hepatic fibrosis.
| Characteristic | Healthy donors, n=25 | Patients (F<2), n=12 | Patients (2≤F<4), n=13 |
|---|---|---|---|
| Age, n (range) | 55.44 (23–84) | 55.83 (25–80) | 56.92 (31–77) |
| Sex, n (%) | |||
| Male | 14 (56) | 7 (58.3) | 5 (38.5) |
| Female | 11 (44) | 5 (41.7) | 8 (61.5) |
| HCV, n (%) | |||
| With | n/a | 2 (16.7) | 3 (23) |
| Without | n/a | 10 (83.3) | 10 (77) |
| Serum ALT, U/l | 35.40±16.92 | 90.92±53.68 | 134.8±86 |
| Serum AST, U/l | 37.52±19.92 | 97.25±64.62 | 150.6±74.8 |
ALT, alanine aminotransferase; AST, aspartate aminotransferase; HCV, hepatitis C virus; n/a, not applicable; FIB-4 (F), fibrosis index based on the 4 factors.